TrialPath
Recruiting

Comparison of Patients With COPD and PRISM

NCT07249567 · Karabuk University
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Comparison of Respiratory and Peripheral Muscle Strength, Exercise Capacity, and Muscle Oxygenation in Individuals With COPD and PRISM
About this study
Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable multisystem lung disease characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, and/or exacerbations) due to airway abnormalities, causing persistent and often progressive airflow limitation. PRISm is defined as a spirometry pattern that is not always a stable phenotype but should be considered "sick" because symptoms and/or functional and/or structural abnormalities are present and therefore require care and treatment. Recently, PRISm has been identified as a subtype more prone to developing COPD or experiencing acute exacerbations. In addition to affecting the respiratory muscles, PRISm's effects on respiratory function lead to decreased body oxygen consumption and increased dyspnea. PRISm can also lead to decreased exercise capacity due to the respiratory problems and dyspnea it causes. Although there are not enough studies in the literature investigating exercise capacity and lung functions on behalf of PRISm, no previous study comparing respiratory muscle strength, peripheral muscle strength and oxygenation in PRISm, COPD and healthy individuals has been found.
Eligibility criteria
Inclusion Criteria: For the COPD group: * Being \>40 years old, * Being diagnosed with COPD, * Being clinically stable, * Volunteering to participate in the study. For the PRISm group: * Being \>40 years old, * Being diagnosed with PRISm, * Volunteering to participate in the study. For the healthy control group: * Being \>40 years old, * Volunteering to participate in the study. Exclusion Criteria: For the COPD group: * Having severe orthopedic, neurological, or cardiac diseases, * Being in a COPD exacerbation, * Having a comorbid lung disease, * Being on clinically unstable medication, * Voluntarily not participating in the study. For the PRISm group: * Being diagnosed with COPD, * Having severe orthopedic, neurological, or cardiac diseases, * Having a comorbid lung disease, * Voluntarily not participating in the study. For the healthy control group: * Having a known chronic disease, * Voluntarily not participating in the study.
Study design
Enrollment target: 60 participants
Age groups: adult, older_adult
Timeline
Starts: 2025-10-05
Estimated completion: 2026-11-30
Last updated: 2025-11-25
Primary outcomes
  • Upper extremity exercise capacity (Baseline)
  • Lower extremity exercise capacity (Baseline)
  • Peripheral muscle strength (Baseline)
Sponsor
Karabuk University · other
Contacts & investigators
ContactMusa Güneş, PhD · contact · musagunes52@hotmail.com · 03704789081
InvestigatorMusa Güneş, PhD · principal_investigator, Karabuk University
InvestigatorRabia Hande Avcı, MD · principal_investigator, Karabuk University
All locations (1)
Karabuk University, Physiotherapy and Rehabilitation Application and Research CenterRecruiting
Karabük, Turkey (Türkiye)
Comparison of Patients With COPD and PRISM · TrialPath